Pneumococcal conjugate second or third-dose vaccines (PCVc) in Costa Rica
Costa Rica: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 98.0% in 2025. β² Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Costa Rica, 2008β2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Costa Rica stood at 98.0%.
The figure is down 1.0% on the previous year and up 4.3% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Costa Rica peaked at 99.0% in 2023 and was at its lowest, 0.0%, in 2008.
Costa Rica ranks 10th of 192 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 24.0% | 0.0% | 48.0% | 2 |
| 2010s | 90.2% | 68.0% | 96.0% | 10 |
| 2020s | 94.8% | 87.0% | 99.0% | 6 |
Countries ranked near Costa Rica
- 10 Turkmenistan 98.0% compare
- 10 El Salvador 98.0% compare
- 10 Portugal 98.0% compare
- 10 Saudi Arabia 98.0% compare
- 10 Mauritius 98.0% compare
More health data for Costa Rica
- Heat deaths vs projected death rates, annual growth rate 0.4617 % change on previous year (2090)
- Heat deaths vs projected death rates 1,632 (2090)
- Un projection of annual infant deaths 35 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 40,311 (2025)
- Age population, age 25, female, interpolated 38,872 (2025)
- Age population, age 24, male, interpolated 39,752 (2025)
- Age population, age 24, female, interpolated 38,260 (2025)
- Age population, age 23, male, interpolated 38,402 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Costa Rica?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Costa Rica was 98.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Costa Rica?
- The highest recorded value was 99.0% in 2023.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Costa Rica?
- The lowest recorded value was 0.0% in 2008.
- How does Costa Rica rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Costa Rica ranks 10th out of 192 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Costa Rica?
- Over the last ten years it is up 4.3%. The long-run trend across the full record is rising.
- Where does this Costa Rica data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV Β· JSON β 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).